IBS and IBD In The News

FDA Recommends Approval of Zelmac for IBS in Women

Novartis June 27, 2000

	Other News
	'Good' Bacteria Controls Pouchitis New Drug Approved for Ulcerative Colitis Sigmoidoscopy Misses Colon Cancers Are Generic Drugs As Good? Emotions May Affect IBS

         The US Food and Drug Administration recommended the approval of Zelmac to treat abdominal pain and constipation in women with Irritable Bowel Syndrome. IBS affects up to 20% of people in the Western population, and symptoms include diarrhea, constipation, and pain.

         Zelmac was well tolerated in a clinical trial involving more than 2,000 patients. A common side effect was diarrhea, which was normally resolved without discontinuing treatment. Other side effects were comparable to the placebo.

Featured Links

IBS 101
The basics about irritable bowel syndrome including symptoms and treatment.

Frequently Asked Questions: IBS
Answers to the most frequently asked questions about IBS.

IBS Drugs
Links to information about other drugs used to treat IBS.

Subscribe to the Newsletter
Name	Email